[
  {
    "Last Name": "Brooks",
    "First Name": "Susan",
    "Display Name": "Former U.S. Congresswoman Susan Brooks",
    "Role in Commission": "Co-Chair",
    "Short Title": "R-IN-5",
    "Title": "R-IN-5",
    "image_field": "https://res.cloudinary.com/csisideaslab/image/upload/v1612448447/health-commission/Brooks_Updated_Photo_xtt8tf.jpg",
    "Has Photo": "TRUE",
    "Short Bio": "Susan W. Brooks is an accomplished former Congresswoman and former US Attorney who has driven key legislation to reform emergency response, healthcare, manufacturing, technology innovation, higher education and public safety. She is known for her bipartisan relationships and as a catalyst for economic development. From 2013-2020, she served as the U.S. Representative for the 5th District of Indiana.",
    "Long Bio": "Susan W. Brooks is an accomplished former Congresswoman and former US Attorney who has driven key legislation to reform emergency response, healthcare, manufacturing, technology innovation, higher education and public safety. Brooks has advised companies, non-profits, educational institutions, and hospitals on operations and workforce planning and development during organizational transformations. She is known for her bipartisan relationships and as a catalyst for economic development. From 2013-2020, she served as the U.S. Representative for the 5th District of Indiana, which spans eight diverse counties throughout the central part of the Hoosier State. \n\nAs a former member of the House Energy and Commerce Committee, Susan held subcommittee roles in Health, Communications and Technology; Commerce, Manufacturing and Trade; and Oversight and Investigations.  She helped shape legislation to improve the health security of Americans through reforms to mental health programs addressing the national heroin and prescription opioid abuse epidemic. Susan also co-founded the 5G Caucus which propelled the United States as a 5G thought leader, driving economic growth and digital innovation. As a former Chair of the Homeland Subcommittee on Emergency Preparedness, Response, and Communications, Susan co-authored the reauthorization of the Pandemic All Hazard Preparedness Act (PAHPA) which strengthened our country’s biodefense response to natural or terrorist related attacks. \n\nSusan is a champion of diversity and inclusion and has elevated Indiana women to leadership positions. She co-chaired the Women’s Caucus and Women in High Tech Coalition and served as the Recruitment Chair for the National Republican Congressional Committee (NRCC). During this time, she recruited a record number of diverse congressional candidates: 94 women and 75 minority candidates on the general election ballot which resulted in a historic victory for the number of Republican women elected.   In addition, Susan served as the Chair for the House Ethics Committee where she reformed deficiencies in the Congressional Accountability Act (CAA) after the #MeToo movement. She oversaw multiple high-profile investigations of Members of Congress during this time.\n\nBrooks earned her Juris Doctorate from Indiana University Robert H. McKinney School of Law and Bachelor of Arts from Miami University in Ohio. Susan has been awarded honorary doctorate degrees from Marian University, IU Robert H. McKinney School of Law, Wabash College, Anderson University and an honorary associate’s degree from Ivy Tech Community College. She is originally from Fort Wayne, Indiana and currently resides in Carmel, Indiana.",
    "signature": "https://res.cloudinary.com/csisideaslab/image/upload/v1576089579/health-commission/Susan_Brooks_oo8q6g.jpg",
    "commission": [
      "2019",
      "2020"
    ]
  },
  {
    "Last Name": "Gerberding",
    "First Name": "Julie",
    "Display Name": "Julie Louise Gerberding, M.D., MPH",
    "Role in Commission": "Co-Chair",
    "Short Title": "Merck & Co, Inc.",
    "Title": "Executive Vice President and Chief Patient Officer, Merck & Co, Inc.",
    "Has Photo": "TRUE",
    "Short Bio": "Dr. Julie Gerberding is Executive Vice President and Chief Patient Officer at Merck, where she is responsible for patient engagement, communications, policy, philanthropic and other functions. She joined Merck in 2010 as president of Merck Vaccines. Dr. Gerberding previously served as Director of the U.S. Centers for Disease Control and Prevention (CDC) from 2002 to 2009.",
    "Long Bio": "Dr. Julie Gerberding is Executive Vice President and Chief Patient Officer at Merck and is responsible for a broad portfolio of patient engagement, communications, policy, philanthropic and other functions. She joined Merck in 2010 as president, Merck Vaccines.\n\nDr. Gerberding served as Director of the U.S. Centers for Disease Control and Prevention (CDC) from 2002 to 2009. She led the agency through more than 40 emergency responses to public health crises.\n\nDr. Gerberding has received more than 50 awards and honors, including the United States Department of Health and Human Services Distinguished Service Award for her leadership in responses to anthrax bioterrorism and the September 11, 2001 attacks. She was named to Forbes Magazine's 100 Most Powerful Women in the world from 2005-2008 and to TIME Magazine's 100 Most Influential People in the World in 2004. In 2018, she was named the Healthcare Business Women’s Association Woman of the Year.\n\nDr. Gerberding received her undergraduate and M.D. degrees from Case Western Reserve University. She completed her internship and residency in Internal Medicine and fellowship in Clinical Pharmacology and Infectious Diseases at the University of California, San Francisco, where she is currently an Adjunct Associate Professor of Medicine. Dr. Gerberding received a Masters of Public Health at the University of California, Berkeley. She is a member of the National Academy of Medicine and a fellow of the Infectious Diseases Society of America and the American College of Physicians. She is board certified in Internal Medicine and Infectious Diseases.\n\nShe serves on the Boards of Cerner Corporation and the MSD Wellcome Trust Hilleman Laboratories, a non-profit that develops new technologies for developing countries.",
    "signature": "https://res.cloudinary.com/csisideaslab/image/upload/v1576089157/health-commission/Julie_Gerberding_stm5xy.jpg",
    "image_field": "https://res.cloudinary.com/csisideaslab/image/upload/v1605907338/health-commission/Gerberding_Julie_xx47m1.jpg",
    "commission": [
      "2019",
      "2020"
    ]
  }
]
